Literature DB >> 20332407

Psychiatrists' relationships with pharmaceutical companies: part of the problem or part of the solution?

Thomas R Insel1.   

Abstract

Mesh：

Year:  2010        PMID： 20332407     DOI： 10.1001/jama.2010.317

Source DB:  PubMed          Journal:  JAMA        ISSN： 0098-7484            Impact factor:   56.272


× No keyword cloud information.
  7 in total

1.  EPA guidance on improving the image of psychiatry.

Authors:  A M Möller-Leimkühler; H-J Möller; W Maier; W Gaebel; P Falkai
Journal:  Eur Arch Psychiatry Clin Neurosci       Date:  2016-02-13       Impact factor: 5.270

2.  Evolution of psychopharmacology trial design and analysis: six decades in the making.

Authors:  Andrew C Leon
Journal:  J Clin Psychiatry       Date:  2011-03       Impact factor: 4.384

3.  What adolescents enrolled in genomic addiction research want to know about conflicts of interest.

Authors:  Marilyn E Coors; Kristen M Raymond; Shannon K McWilliams; Christian J Hopfer; Susan K Mikulich-Gilbertson
Journal:  Drug Alcohol Depend       Date:  2014-12-15       Impact factor: 4.492

4.  Reporting bias in industry-supported medication trials presented at the American Psychiatric Association meeting.

Authors:  Srijan Sen; Maya Prabhu
Journal:  J Clin Psychopharmacol       Date:  2012-06       Impact factor: 3.153

Review 5.  Conflict of interest in clinical practice guideline development: a systematic review.

Authors:  Susan L Norris; Haley K Holmer; Lauren A Ogden; Brittany U Burda
Journal:  PLoS One       Date:  2011-10-19       Impact factor: 3.240

6.  Interactions between physicians and pharmaceutical sales representatives in Saudi Arabia.

Authors:  Fahad Dakheel Alosaimi; Abdulaziz Alkaabba; Mahdi Qadi; Abdullah Albahlal; Yasir Alabdulkarim; Mohammad Alabduljabbar; Faisal Alqahtani
Journal:  Ann Saudi Med       Date:  2013 Nov-Dec       Impact factor: 1.526

7.  Risk Model Assessment in Early-Onset and Adult-Onset Schizophrenia Using Neurological Soft Signs.

Authors:  Bao-Yu Chen; I-Ning Tsai; Jin-Jia Lin; Ming-Kun Lu; Hung-Pin Tan; Fong-Lin Jang; Shu-Ting Gan; Sheng-Hsiang Lin
Journal:  J Clin Med       Date:  2019-09-11       Impact factor: 4.241
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.